These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 17199432
1. HLA-DR3 transgenic mice immunized with adenovirus encoding the thyrotropin receptor: T cell epitopes and functional analysis of the CD40 Graves' polymorphism. Pichurin P, Pham N, David CS, Rapoport B, McLachlan SM. Thyroid; 2006 Dec; 16(12):1221-7. PubMed ID: 17199432 [Abstract] [Full Text] [Related]
2. Thyrotropin Receptor-Specific Lymphocytes in Adenovirus-TSHR-Immunized Native and Human Leukocyte Antigen-DR3-Transgenic Mice and in Graves' Disease Patient Blood. Degen H, Gavvovidis I, Blankenstein T, Uhland K, Ungerer M. Thyroid; 2021 Jun; 31(6):950-963. PubMed ID: 33208049 [Abstract] [Full Text] [Related]
3. Thyrotropin receptor-DNA vaccination of transgenic mice expressing HLA-DR3 or HLA-DQ6b. Pichurin P, Chen CR, Pichurina O, David C, Rapoport B, McLachlan SM. Thyroid; 2003 Oct; 13(10):911-7. PubMed ID: 14611699 [Abstract] [Full Text] [Related]
4. Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves' disease. Li CW, Osman R, Menconi F, Concepcion E, Tomer Y. J Autoimmun; 2020 Mar; 108():102402. PubMed ID: 31980336 [Abstract] [Full Text] [Related]
6. Epitope recognition in HLA-DR3 transgenic mice immunized to TSH-R protein or peptides. Inaba H, Moise L, Martin W, De Groot AS, Desrosiers J, Tassone R, Buchman G, Akamizu T, De Groot LJ. Endocrinology; 2013 Jun; 154(6):2234-43. PubMed ID: 23592747 [Abstract] [Full Text] [Related]
7. Thyrotropin receptor epitopes and their relation to histocompatibility leukocyte antigen-DR molecules in Graves' disease. Inaba H, Martin W, De Groot AS, Qin S, De Groot LJ. J Clin Endocrinol Metab; 2006 Jun; 91(6):2286-94. PubMed ID: 16595602 [Abstract] [Full Text] [Related]
8. The role of glutamic or aspartic acid in position four of the epitope binding motif and thyrotropin receptor-extracellular domain epitope selection in Graves' disease. Inaba H, Martin W, Ardito M, De Groot AS, De Groot LJ. J Clin Endocrinol Metab; 2010 Jun; 95(6):2909-16. PubMed ID: 20392871 [Abstract] [Full Text] [Related]
10. Peptide scanning for thyrotropin receptor T-cell epitopes in mice vaccinated with naked DNA. Pichurin P, Schwarz-Lauer L, Braley-Mullen H, Paras C, Pichurina O, Morris JC, Rapoport B, McLachlan SM. Thyroid; 2002 Sep; 12(9):755-64. PubMed ID: 12481940 [Abstract] [Full Text] [Related]
11. Blockade of costimulation between T cells and antigen-presenting cells: an approach to suppress murine Graves' disease induced using thyrotropin receptor-expressing adenovirus. Chen CR, Aliesky HA, Guo J, Rapoport B, McLachlan SM. Thyroid; 2006 May; 16(5):427-34. PubMed ID: 16756463 [Abstract] [Full Text] [Related]
12. Binding of human thyrotropin receptor peptides to a Graves' disease-predisposing human leukocyte antigen class II molecule. Sawai Y, DeGroot LJ. J Clin Endocrinol Metab; 2000 Mar; 85(3):1176-9. PubMed ID: 10720058 [Abstract] [Full Text] [Related]
13. Relationship between thyroid peroxidase T cell epitope restriction and antibody recognition of the autoantibody immunodominant region in human leukocyte antigen DR3 transgenic mice. Guo J, McLachlan SM, Pichurin PN, Chen CR, Pham N, Aliesky HA, David CS, Rapoport B. Endocrinology; 2005 Nov; 146(11):4961-7. PubMed ID: 16081633 [Abstract] [Full Text] [Related]
14. Targeted expression of the human thyrotropin receptor A-subunit to the mouse thyroid: insight into overcoming the lack of response to A-subunit adenovirus immunization. Pichurin PN, Chen CR, Chazenbalk GD, Aliesky H, Pham N, Rapoport B, McLachlan SM. J Immunol; 2006 Jan 01; 176(1):668-76. PubMed ID: 16365463 [Abstract] [Full Text] [Related]
15. Role of the transgenic human thyrotropin receptor A-subunit in thyroiditis induced by A-subunit immunization and regulatory T cell depletion. Mizutori Y, Nagayama Y, Flower D, Misharin A, Aliesky HA, Rapoport B, McLachlan SM. Clin Exp Immunol; 2008 Dec 01; 154(3):305-15. PubMed ID: 18811696 [Abstract] [Full Text] [Related]
16. Cathepsin S is not crucial to TSHR processing and presentation in a murine model of Graves' disease. Kala M, Chen CR, McLachlan SM, Rapoport B, Aliesky H, Chapman HA. Immunology; 2005 Dec 01; 116(4):532-40. PubMed ID: 16313367 [Abstract] [Full Text] [Related]
17. Enhancement of experimental Graves' disease by intranasal administration of a T cell epitope of the thyrotropin receptor. Arima T, Shimojo N, Yamaguchi K, Tomiita M, Kohn LD, Kohno Y. Clin Immunol; 2008 Apr 01; 127(1):7-13. PubMed ID: 18234558 [Abstract] [Full Text] [Related]
18. The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain. Kikuoka S, Shimojo N, Yamaguchi KI, Watanabe Y, Hoshioka A, Hirai A, Saito Y, Tahara K, Kohn LD, Maruyama N, Kohno Y, Niimi H. Endocrinology; 1998 Apr 01; 139(4):1891-8. PubMed ID: 9528975 [Abstract] [Full Text] [Related]
19. Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell-induced Graves' hyperthyroidism in mice. Mizutori Y, Saitoh O, Eguchi K, Nagayama Y. J Autoimmun; 2006 Feb 01; 26(1):32-6. PubMed ID: 16242303 [Abstract] [Full Text] [Related]
20. T-cells recognize multiple epitopes in the human thyrotropin receptor extracellular domain. Soliman M, Kaplan E, Yanagawa T, Hidaka Y, Fisfalen ME, DeGroot LJ. J Clin Endocrinol Metab; 1995 Mar 01; 80(3):905-14. PubMed ID: 7533773 [Abstract] [Full Text] [Related] Page: [Next] [New Search]